CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 82 enrolled
Drug / intervention
Intramuscular methylprednisolone acetate +1 moredrug
Likely dose
Intramuscular methylprednisolone acetate 160mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00290589
NCT00290589Phase 3Completed
CompareCT.gov

Utility of Intramuscular Corticosteroids for Radicular Low Back Pain

Montefiore Medical Center·interventional·Posted Feb 13, 2006·Updated Aug 7, 2019

In Brief

A Phase 3 clinical trial evaluating Intramuscular methylprednisolone acetate and Placebo for Radicular Low Back Pain. Completed, enrolled 82 participants across 1 site.

Detailed Summary

Low back pain is a common symptom that functionally disables many people. When the low back pain is accompanied by pain that shoots down the leg, it is felt to be caused by a herniated disc. We are conducting this study to determine if a powerful anti-inflammatory agent will decrease the pain and functional impairment that is associated with this illness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRadicular Low Back Pain
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 13, 2006
Enrollment StartJun 1, 2003
Primary CompletionAug 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 20.4 years ago

Interventions

Intramuscular methylprednisolone acetatedrug

Intramuscular methylprednisolone acetate 160mg

Placebodrug

Normal saline intramuscular injection